De Novo Mutation in KMT2C Manifesting as Kleefstra Syndrome 2: Case Report and Literature Review.
KMT2C
Kleefstra syndrome 2
intellectual disability
Journal
Pediatric reports
ISSN: 2036-749X
Titre abrégé: Pediatr Rep
Pays: Switzerland
ID NLM: 101551542
Informations de publication
Date de publication:
11 Mar 2022
11 Mar 2022
Historique:
received:
30
12
2021
revised:
08
03
2022
accepted:
09
03
2022
entrez:
24
3
2022
pubmed:
25
3
2022
medline:
25
3
2022
Statut:
epublish
Résumé
Diagnosis of pediatric intellectual disability (ID) can be difficult because it is due to a vast number of established and novel causes. Here, we described a full-term female infant affected by Kleefstra syndrome-2 presenting with neurodevelopmental disorder, a history of hypotonia and minor face anomalies. A systematic literature review was also performed. The patient was a 6-year-old Caucasian female. In the family history there was no intellectual disability or genetic conditions. Auxological parameters at birth were adequate for gestational age. Clinical evaluation at 6 months revealed hypotonia and, successively, delay in the acquisition of the stages of psychomotor development. Auditory, visual, somatosensory, and motor-evoked potentials were normal. A brain MRI, performed at 9 months, showed minimal gliotic changes in bilateral occipital periventricular white matter. Neuropsychiatric control, performed at 5 years, established a definitive diagnosis of childhood autism and developmental delay. Molecular analysis of the exome revealed a novel KMT2C missense variant: c.9244C > T (p.Pro3082Ser) at a heterozygous state, giving her a diagnosis of Kleefstra syndrome 2. Parents did not show the variant. Literature review (four retrieved eligible studies, 10 patients) showed that all individuals had mild, moderate, or severe ID; language and motor delay; and autism. Short stature, microcephaly, childhood hypotonia and plagiocephaly were also present. Conclusion. Kleefstra syndrome 2 is a difficult diagnosis of a rare condition with a high clinical phenotypic heterogeneity. This study suggests that it must be taken in account in the work-up of an orphan diagnosis of intellectual disability and/or autism spectrum disorder.
Identifiants
pubmed: 35324822
pii: pediatric14010019
doi: 10.3390/pediatric14010019
pmc: PMC8954887
doi:
Types de publication
Case Reports
Langues
eng
Pagination
131-139Références
Sci Rep. 2019 Nov 11;9(1):16469
pubmed: 31712638
Genet Med. 2020 Jul;22(7):1269-1275
pubmed: 32366967
Clin Epigenetics. 2020 Jan 10;12(1):10
pubmed: 31924266
Philos Trans R Soc Lond B Biol Sci. 2014 Sep 26;369(1652):
pubmed: 25135975
Adv Ment Health Intellect Disabil. 2016;10(1):36-58
pubmed: 27066217
N Engl J Med. 2012 Feb 23;366(8):733-43
pubmed: 22356326
Pediatr Rev. 2012 Mar;33(3):110-21; quiz 120-1
pubmed: 22383514
Am J Hum Genet. 2012 Jul 13;91(1):73-82
pubmed: 22726846
Am J Hum Genet. 2018 Jan 4;102(1):175-187
pubmed: 29276005
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nature. 2014 Apr 10;508(7495):199-206
pubmed: 24695229
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
PLoS Genet. 2017 Oct 25;13(10):e1006864
pubmed: 29069077